Alunbrig

Brigatinib · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Alunbrig, covering 2017-04-28 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping [Phase 2]